Clinical characteristics influence screening intervals for diabetic retinopathy. (Q51219025)

1 April 2018

title

Clinical characteristics influence screening intervals for diabetic retinopathy. (English)

1 reference

1 April 2018

author

Massimo Porta

1

1 reference

1 April 2018

Paola Dalmasso

12

1 reference

1 April 2018

Marina Trento

object named as

Marina Trento

5

0 references

author name string

Mauro Maurino

2

1 reference

1 April 2018

Sara Severini

3

1 reference

1 April 2018

Elena Lamarmora

4

1 reference

1 April 2018

Elena Sitia

6

1 reference

1 April 2018

Eleonora Coppo

7

1 reference

1 April 2018

Alessandro Raviolo

8

1 reference

1 April 2018

Stefania Carbonari

9

1 reference

1 April 2018

Marcello Montanaro

10

1 reference

1 April 2018

Lorenza Palanza

11

1 reference

1 April 2018

Franco Cavallo

13

1 reference

1 April 2018

publication date

5 July 2013

1 reference

1 April 2018

published in

Diabetologia

1 reference

1 April 2018

volume

56

1 reference

1 April 2018

page(s)

2147-2152

1 reference

1 April 2018

issue

10

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-013-2989-7

exact match

0 references

cites work

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

The case for biennial retinopathy screening in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

New blindness in diabetes reduced by more than one-third in Stockholm County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Screening and prevention of diabetic blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

A simple risk stratification for time to development of sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2989-7

Standards of medical care in diabetes--2012

21 January 2018

1 reference

12 December 2020

Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study

1 reference

12 December 2020

Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures

1 reference

12 December 2020

A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party

1 reference

12 December 2020

Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

10.1007/S00125-013-2989-7

Identifiers

DOI

1 reference

1 April 2018

PubMed ID

23827966

1 reference

1 April 2018